The effect of the cyclin D1 (CCND1) A870G polymorphism on colorectal cancer risk is modified by glutathione-S-transferase polymorphisms and isothiocyanate intake in the Singapore Chinese Health Study

Carcinogenesis

Volumn 27, Issue 12, 2006, Pages 2475-2482

  Probst Hensch, Nicole M ^a   Sun, Can Lan ^b   Van Den Berg, David ^c   Ceschi, Michela ^a   Koh, Woon Puay ^d   Yu, Mimi C ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; GENOMIC DNA; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; ISOTHIOCYANIC ACID;

APOPTOSIS; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CELL PROLIFERATION; CLINICAL TRIAL; COHORT ANALYSIS; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SINGAPORE; SINGLE NUCLEOTIDE POLYMORPHISM;

BASE SEQUENCE; BODY MASS INDEX; COLORECTAL NEOPLASMS; CYCLINS; DIET; DNA PRIMERS; ETHNIC GROUPS; FEMALE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; INCIDENCE; ISOTHIOCYANATES; MALE; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RISK FACTORS; SINGAPORE;

EID: 33845353379     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgl116     Document Type: Article

References (61)

1. Sherr,C.J. (1996) Cancer cell cycles. Science, 274, 1672-1677.
2. Malumbres,M. and Barbacid,M. (2001) To cycle or not to cycle: A critical decision in cancer. Nat. Rev. Cancer, 1, 222-231.
3. Ortega,S., Malumbres,M. and Barbacid,M. (2002) Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim. Biophys. Acta, 1602, 73-87.
4. Cook,S.J., Balmanno,K., Garner,A., Millar,T., Taverner,C. and Todd,C. (2002) Regulation of cell cycle re-entry by growth, survival and stress signalling pathways. Biochem. Soc. Trans., 28, 233-240.
5. Hunter,T. and Pines,J. (1994) Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell, 79, 573-582.
6. Knudsen,K.E, Diehl,J. A., Haiman,C.A. and Knudsen,E.S. (2006) Cyclin D1: polymorphism, aberrant splicing and cancer risk. Oncogene, 25, 1620-1628.
7. Betticher,D.C., Thatcher,N., Altermatt,H.J., Hoban,P., Ryder,W.D. and Heighway,J. (1995) Alternate splicing produces a novel cyclin D1 transcript. Oncogene, 11, 1005-1011.
8. Holley,S.L, Parkes,G., Matthias,C., Bockmuhl,U., Jahnke,V., Leder,K., Strange,R.C., Fryer,A.A. and Hoban,P.R. (2001) Cyclin D1 polymorphism and expression in patients with squamous cell carcinoma of the head and neck. Am. J. Pathol., 159, 1917-1924.
9. Howe,D. and Lynas,C. (2001) The cyclin D1 alternative transcripts [a] and [b] are expressed in normal and malignant lymphocytes and their relative levels are influenced by the polymorphism at codon 241. Haematologica, 86, 563-569.
10. Bala,S. and Peltomaki,P. (2001) Cyclin D1 as a genetic modifier of hereditary nonpolyposis colorectal cancer. Cancer Res., 61, 6042-6045.
11. Ceschi,M., Sun,C.-L., Van den Berg,D., Koh,W.-P., Yu,M.C. and Probst-Hensch,N.M. (2005) The effect of cyclin D1 (CCND1) G870Apolymorphism on breast cancer risk is modified by oxidative stress among Chinese women in Singapore. Carcinogenesis, 26, 1457-1464.
12. Le Marchand,L., Seifried,A., Lum-Jones,A., Donlon,T. and Wilkens,L.R. (2003) Association of the cyclin D1 A870G polymorphism with advanced colorectal cancer. JAMA, 290, 2843-2848.
13. Grieu,F., Malaney,S., Ward,R., Joseph,D. and Iacopetta,B. (2003) Lack of association between CCND1 G870A polymorphism and the risk of breast and colorectal cancers. Anticancer Res., 23, 4257-4259.
14. Hong,Y., Eu,K.W., Seow.Choen,F., Fook-Chong,S. and Cheah,P.Y. (2005) GC genotype of cyclin D1 G870A polymorphism is associated with increased risk and advanced colorectal cancer in patients in Singapore. Carcinogenesis, 41, 1037-1044.
15. Kong,S., Amos,C.I., Luthra,R., Lynch,P.M., Levin,B. and Frazier,M.L. (2000) Effects of cyclin D1 polymorphism on age of onset of hereditary nonpolyposis colorectal cancer. Cancer Res., 60, 249-252.
16. Kong,S., Wei,Q., Amos,C.I., Lynch,P.M., Levin,B., Zong,J. and Frazier,M.L. (2001) Cyclin D1 polymorphism and increased risk of colorectal cancer at young age. J. Natl Cancer Inst., 93, 106-1108.
17. Porter,T.R., Richards,F.M., Houlston,R.S. et al. (2002) Contribution of cyclin d1 (CCND1) and E-cadherin (CDH1) polymorphisms to familial and sporadic colorectal cancer. Oncogene, 21, 1928-1933.
18. McKay,J.A., Douglas,J.J., Ross,V.G., Curran,S., Murray,G.I., Cassidy,J. and McLeod,H.L. (2000) Cyclin D1 protein expression and gene polymorphism in colorectal cancer. Aberdeen Colorectal Initiative. Int. J. Cancer, 88, 77-81.
19. Lewis,R.C., Bostick,R.M., Xie,D., Deng,Z., Wargovich,M.J., Fina,M.F., Roufail,W.M. and Geisinger,K.R. (2003) Polymorphism of the cyclin D1 gene, CCND1 and risk for incident sporadic colorectal adenomas. Cancer Res., 63, 8549-8553.
20. Schernhammer,E.S., Tranah,G.J., Giovanucci,E., Chan,A.T., Ma,J., Colditz,G.A., Hunter,D.J., Willett,W.C. and Fuchs,C.S. (2006) Cyclin D1 A870G polymorphism and the risk of colorectal cancer and adenoma. Br. J. Cancer, 94, 928-934.
21. Seow,A., Yuan,J.-M., Sun,C.-L., Van Den Berg,D., Lee,H.-P. and Yu,M.C. (2002) Dietary isothiocyanates, glutathione S-transferase polymorphisms and colorectal cancer risk in the Singapore Chinese Health Study. Carcinogenesis, 12, 2055-2061.
22. Murillo,G. and Mehta,R.G. (2001) Cruciferious vegetables and cancer prevention. Nutr. Cancer, 41, 17-28.
23. Zhang,Y. and Talalay,P. (1994) Anticarcinogenic activities of organic isothiocyanates: Chemistry and mechanisms. Cancer Res., 54, 1976-1981.
24. Hankin,J.H., Stram,D.O., Arakawa,K., Park,S., Low,S.H., Lee,H.-P. and Yu,M.C. (2001) Singapore Chinese Health Study: Development, validation and calibration of the quantitative food frequency questionnaire. Nutr. Cancer, 39, 187-195.
25. Lum,A. and Le Marchand,L. (1998) A simple mouthwash method for obtaining genomic DNA in molecular epidemiological studies. Cancer Epidemiol. Biomarker Prev., 7, 719-724.
26. Seow,A., Koh,W.P., Chia,K.S., Shi,L.M., Lee,H.P. and Shanmugaratnam,K.S. (2004) Trends in Cancer Incidence in Singapore, 1968-2002. The Singapore Cancer Registry Report No. 6. Singapore.
27. Lee,L.G., Connell,C.R. and Bloch,W. (1993) Allelic discremination by nick-translation PCR with fluorogenic probes. Nucleic Acids Res., 21, 3761-3766.
28. Wang,L., Habuchi,T., Takahashi,T. et al. (2002) Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer. Carcinogenesis, 23, 257-264.
29. Breslow,N.E. and Day,N.E. (1980) Statistical Methods in Cancer Research I: The Analysis of Case-Control Studies. IARC Scientific Publications, Vol. 32, IARC, Lyon.
30. Hu,X., Xia,H., Srivastava,S.K. et al. (1997) Activity of four allelic forms of glutathione S-transferase hGSTP1-1 for diol epoxides of polycyclic hydrocarbons. Biochem. Biophys. Res. Commun., 238, 397-402.
31. Harries,L.W., Stubbins,M.J., Forman,D., Howard,G.C.W. and Wolf,C.R. (1997) Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis, 18, 641-644.
32. Hosmer,W. and Lemeshow,S. (1989) Polytomous Logistic Regression. In: Hosmer,W. and Lemeshow,S., (eds) Applied Logistic Regression. John Wiley & Sons, New York, pp. 216-245.
33. Shackelford,R.E., Kaufmann,W.K. and Paules,R.S. (2000) Oxidative stress and cell cycle checkpoint function. Free Radic. Biol. Med., 28, 1387-1404.
34. Burch,P.M. and Heintz,N.H. (2005) Redox regulation of cell-cycle re-entry: Cyclin D1 as a primary target for the mitogenic effects of reactive oxygen and nitrogen species. Antioxid. Redox Signal, 7, 741-751.
35. Loo,G. (2003) Redox-sensitive mechanisms of phytochemical-mediated inhibition of cancer cell proliferation. J. Nutr. Biochem., 14, 64-73.
36. Bowerman,B. (2005) Oxidative stress and cancer: A β-catenin convergence. Science, 308, 1119-1120.
37. Tetsu,O. and McCormick,F. (1999) β-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature, 398, 422-426.
38. Shen,G., Xu,C., Chen,C., Hebbar,V. and Kong,A.N. (2006) p53-independent G(1) cell cycle arrest of human colon carcinoma cells HT-29 by sulforaphane is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1. Cancer Chemother. Pharmacol., 57, 317-327.
39. Chiao,J.W., Chung,F.L., Kancherla,R., Ahmed,T., Mittelman,T., Mittelman,A. and Conaway,C.C. (2002) Sulforaphane and its metabolite mediate growth arrest and apoptosis in human prostate cancer cells. Int. J. Oncol., 20, 631-636.
40. Gamet-Payrastre,L., Li,P., Lumeau,S., Cassar,G., Dupont,M.A., Chevolleau,S., Gasc,N., Tulliez,J. and Terce,F. (2000) Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells. Cancer Res., 60, 1426-1433.
41. Srivastava,S.K. and Singh,S.V. (2004) Cell cycle arrest, apoptosis induction and inhibition of nuclear factor kappa B activation in antiproliferative activity of benzyl isothiocyanate against human pancreatic cancer cells. Carcinogenesis, 25, 1701-1709.
42. Firestone,G.L. and Bjeldanes,L.F. (2003) Indole-3-carbinol and 3-3′- Diindolylmethane antiproliferative signalling pathways control cell cycle gene transcription in human breast cancer cells by regulating promoter-Sp1 transcription factor interactions. J. Nutr., 133, 2448S-2455S.
43. Lund,E. (2003) Non-nutritive bioactive constituents of plants: Dietary sources and health benefits of glucosinolates. Int. J. Vitam. Nutr. Res., 73, 135-143.
44. Zhang,Y., Tang,L. and Gonzalez,V. (2003) Selected isothiocyanates rapidly induce growth inhibition of cancer cells. Mol. Cancer Ther., 2, 1045-1052.
45. Brandi,G., Paiardini,M., Cervasi,B., Fiorucci,C., Filippone,P., De Marco,C., Zaffaroni,N. and Magnani,M. (2003) A new indole-3-carbinol tetrameric derivative inhibits cyclin-dependent kinase 6 expression and induces G1 cell cycle arrest in both estrogen-dependent and estrogen-independent breast cancer cell lines. Cancer Res., 63, 4028-4036.
46. Wang,L., Liu,D., Ahmed,T., Chung,F.-L., Conaway,C. and Chiao,J.-W. (2004) Targeting cell cycle machinery as a molecular mechanism of sulforaphane in prostate cancer prevention. Int. J. Oncol., 24, 187-192.
47. Pham,N.-A., Jacobberger,J.W., Schimmer,A.D., Cao,P., Gronda,M. and Hedley,D.W. (2004) The dietary isothiocyanate sulforaphane targets pathways of apoptosis, cell cycle arrest and oxidative stress in human pancreatic cancer cells and inhibits tumor growth in severe combined immunodeficient mice. Mol. Cancer Ther., 3, 1239-1248.
48. Lin,H.J., Probst-Hensch,N.M., Louie,A.D., Kau,I.H., Witte,J.S., Ingles,S.A., Frankl,H.D., Lee,E.R. and Haile,R.W. (1998) Glutathione transferase null genotype, broccoli and lower prevalence of colorectal adenomas. Cancer Epidemiol. Biomarkers Prev., 7, 647-652.
49. Pagano,M., Theodoras,A.M., Tam,S.W. and Draetta,G.F. (1994) Cyclin D1-mediated inhibition of repair and replicative DNA synthesis in human fibroblasts. Genes Dev., 8, 1627-1639.
50. Quelle,D.E., Ashmun,R.A., Shurtleff,S.A., Kato,J.Y., Bar-Sagi,D., Roussel,M.F. and Sherr,C.J. (1993) Overexpression of mouse D-type cyclins accelerates G1-phase in rodent fibroblasts. Genes Dev., 7, 1559-1571.
51. Kinoshita,A., Wanibuchi,H., Imaoka,S., Ogawa,M., Masuda,C., Morimura,K., Funae,Y. and Fukushima,S. (2002) Formation of 8-hydroxydeoxyguanosine and cell-cycle arrest in the rat liver via generation of oxidative stress by phenobarbital: Association with expression profiles of p21(WAF1/Cip1), cyclin D1 and Ogg1. Carcinogenesis, 23, 341-349.
52. Turner,B.C., Gumbs,A.A., Carter,D., Glazer,P.M. and Haffty,B.G. (2000) Cyclin D1 expression and early breast cancer recurrence following lumpectomy and radiation. Int. J. Radiat. Oncol. Biol. Phys., 47, 1169-1176.
53. Pardo,F.S., Su,M. and Borek,C. (1996) Cyclin D1 induced apoptosis maintains the integrity of the G1/S checkpoint following ionizing radiation irradiation. Somat. Cell Mol. Genet., 22, 135-144.
54. Coco Martin,J.M., Balkenende,A., Verschoor,T., Lallemand,F. and Michalides,R. (1999) Cyclin D1 overexpression enhances radiation-induced apoptosis and radiosensitivity in a breast tumor cell line. Cancer Res., 59, 1134-1140.
55. Rowland,B.D. and Peeper,D.S. (2006) KLF4, p21 and context-dependent opposing forces in cancer. Nat. Rev. Cancer, 6, 11-23.
56. Solomon,D.A., Wang,Y., Fox,S.R., Lambeck,T.C. and Giesting,S. (2003) Cyclin D1 splice variants. J. Biol. Chem., 278, 30339-30347.
57. Sawa,H., Ohshima,T.A., Ukita,H., Murakami,H., Chiba,Y., Kamada,H., Hara,M. and Saito,I. (1998) Alternatively spliced forms of cyclin D1 modulate entry into the cell cycle in an inverse manner. Oncogene, 16, 1701-1712.
58. Kolonel,L.N., Henderson,B.E., Hankin,J.H., Nomura,A.M.Y., Wilkens,L.R., Pike,M.C., Stram,D.O., Monroe,K.R., Earle,M.E. and Nagamine,F.S. (2000) A multiethnic cohort in Hawaii and Los Angeles: Baseline characteristics. Am. J. Epidemiol., 151, 346-357.
59. Seow,A., Shi,C.Y., Chung,F.L., Jiao,D., Hankin,J.H., Lee,J.P., Coetzee,G.A. and Yu,M.C. (1998) Urinary isothiocyanate (ITC) in a population-based sample of middle-aged and older Chinese in Singapore: relationship with dietary total ITC and glutathione S-transferase M1/T1/ P1 genotypes. Cancer Epidemiol. Biomarkers Prev., 7, 775-781.
60. Buch,S., Zhu,B., Davis,A.G., Odom,D., Siegfried,J.M., Grandis,J.R. and Romkes,M. (2005) Association of polymorphisms in the cyclin D1 and XPD genes and susceptibility to cancers of the upper aerodigestive tract. Mol. Carcinog., 42, 222-228.
61. Shu,X.O., Moore,D.B., Cai,Q., Cheng,J., Wen,W., Pierce,L., Cai,H., Gao,Y.T. and Zheng,W. (2005) Association of cyclin D1 genotype with breast cancer risk and survival. Cancer Epidemiol. Biomarkers Prev., 14, 91-97.